2017
DOI: 10.1093/schbul/sbx021.029
|View full text |Cite
|
Sign up to set email alerts
|

10. Brain Structure Biomarkers at the Psychosis/Nonpsychosis Interphase: Findings From the Bipolar–Schizophrenia Network for Intermediate Phenotypes

Abstract: International Congress on Schizophrenia Research S10 Plenary correlated with AL at trend level (adjusted R = −.251, P = .070). No significant associations were found for negative symptoms (P = .582). AL decreased after treatment with olanzapine, risperidone, or quetiapine was commenced in patients with SCZ and FEP between the baseline assessment and the 6-and 12-week follow-up. Conclusion: Our data provide evidence for cumulative physiological dysregulation in patients with SCZ and FEP that is linked to the ex… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles